• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
For: Rollins BL. Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". Int J Health Policy Manag 2016;5:287-8. [PMID: 27239875 DOI: 10.15171/ijhpm.2016.17] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2015] [Accepted: 02/08/2016] [Indexed: 11/09/2022]  Open
Number Cited by Other Article(s)
1
Applequist J, Hintz EA, Quichocho D, Chesser S, Price D, Sturgess S, Giardino M, Young HN. Information versus influence: An analysis of educational, relational, and identity rewards present in direct-to-consumer prescription drug advertising. J Am Pharm Assoc (2003) 2021;61:795-803. [PMID: 34238672 DOI: 10.1016/j.japh.2021.06.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2021] [Revised: 06/15/2021] [Accepted: 06/17/2021] [Indexed: 10/21/2022]
2
Kim H. Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries. Int J Health Policy Manag 2016;5:611-612. [PMID: 27694655 DOI: 10.15171/ijhpm.2016.92] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2016] [Accepted: 07/02/2016] [Indexed: 11/09/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA